Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset

By sjmartinez • March 8, 2024

Channick R, Chin KM, McLaughlin VV, Lammi MR, Zamanian RT, Turricchia S, Ong R, Mitchell L, Kim NH. Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset. Cardiol Ther. 2024 Mar 7. doi: 10.1007/s40119-024-00361-w. Epub ahead of print. PMID: 38451426.

Tags: Connective tissue disease, Macitentan, Mixed connective tissue disease, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, real-world evidence, Scleroderma, systemic lupus erythematosus, systemic sclerosis

Effect of Glucagon-Like Peptide 1 Receptor Agonists on Patients With Rheumatoid Arthritis

Kellner DA, Dente E, Tran V, Welsh T, Tran V, Saha A, Baker JF, Elashoff DA, Ranganath VK. Effect of Glucagon-Like Peptide 1 Receptor Agonists[...]

Demographics and Trends of Sudden Cardiac Death-Related Mortality in the United States, 1999 to 2022

Jaiswal V, Kumar D, Mashkoor Y, Latif F, Kanagala SG, Halder A, Jaiswal A, Bandyopadhyay D, Hajra A, Joshi A, Aronow WS, Fonarow GC. Demographics[...]

Machine Learning to Diagnose Complications of Diabetes

Scheideman AF, Shao MM, Zelada H, Cuadros J, Foreman J, Sarder P, Ho C, Ejskjaer N, Fleischer J, Cichosz SL, Armstrong DG, Mathioudakis N, Wang[...]